Therefore, this study comprehensively analysed the relationship between RFC4 expression and the prognostic value of cancer, associated pathways, DNA methylation, variable shearing, immune microenvironment, immune response and drug sensitivity to assess the oncogenic role of RFC4 and its impact on pan‐cancer immunity and therapy using multiple databases. This evidence concerns the gene RFC4 and cancer.